Addiction Biology · 2011 · 16 citations · 31 references
MedicineBehavioral SciencesPharmacologyBehavioral PharmacologyNeuropharmacologyPsychopharmacologyAnalgesiaConditioned Place PreferenceDrug DiscriminationOpioid AnalgesicsOpioid PharmacologyReceptor PharmacologyAversive LearningDiscriminative StimulusKappa Opioid Receptor PharmacologyN-methyl-d-aspartate Receptor AntagonismOpioid DiscriminationOpioid Receptor AgonistsOpioid System Modulation
The present study was undertaken to identify possible similarities between the effects of kappa-opioid receptor agonist, N-methyl-D-aspartate-receptor antagonist, and sigma receptor agonist on the discriminative stimulus effects of U-50488H, and the possible involvement of sigma receptors in the discriminative stimulus and aversive effects of U-50488H. The kappa-opioid receptor agonist U-50488H produced significant place aversion as measured by the conditioned place preference procedure, and this effect was completely abolished by treatment with the putative sigma-1 receptor antagonist NE-100. In addition, phencyclidine (+)-SKF-10047 and (+)-pentazocine, which are sigma receptor agonists, generalized to the discriminative stimulus effects of U-50488H in rats that had been trained to discriminate between U-50488H (3.0 mg/kg) and saline. Furthermore, NE-100 significantly attenuated the discriminative stimulus effects of U-50488H and the U-50488H-like discriminative stimulus effects of phencyclidine. These results suggest that the sigma-1 receptor is responsible for both the discriminative stimulus effects and aversive effects of U-50488H.
31
Endogenous opioid peptides: multiple agonists and receptors
John A.H. Lord, Angela A. Waterfield, John Hughes et al. · Nature · 1977 · 2.5K citations
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Robert C. Hastings · JAMA · 1996 · 2.4K citations
Yong Zhang, Eduardo R. Butelman, Stefan D. Schlussman et al. · Psychopharmacology · 2005 · 198 citations
Medicine, Neuroscience, Pharmacology +13